William Hill shareholder questions “weaponised” contractual terms of Caesars takeover
HBK Investments to contest upcoming scheme court hearing amid claim shareholders were misled by “poison pill” restricted acquirer terms
You're reading subscriber-only content
Unlock full access to this insight